Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhPTH(1-34) versus elcatonin in postmenopausal osteoporosis
ChiCTR-TRC-11001313Phase 4Completed
- Sponsor
- Gangyi Yang
- Start
- Jan 2010
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of teriparatide and elcatonin in postmenopausal osteoporosis (2 arms), sponsored by Gangyi Yang. Primary endpoints: Bone mineral density and Bone metabolism-related factors. Started Jan 2010; status: completed.
02
Drugs
teriparatideelcatonin
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on ChiCTR-TRC-11001313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001313.